Literature DB >> 33220153

Assessment of quality of life in Gaucher disease: A methodological approach.

Vitória S Zizemer1, Tatiele Nalin2, Ida Vanessa D Schwartz3,4, Ana Paula Vanz5.   

Abstract

Entities:  

Year:  2020        PMID： 33220153      PMCID： PMC7963409          DOI： 10.1002/mgg3.1549

Source DB:  PubMed          Journal:  Mol Genet Genomic Med        ISSN： 2324-9269            Impact factor:   2.183


× No keyword cloud information.
  2 in total

1.  The measurement of performance in childhood cancer patients.

Authors:  S B Lansky; M A List; L L Lansky; C Ritter-Sterr; D R Miller
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

2.  Improvement of life quality measured by Lansky Score after enzymatic replacement therapy in children with Gaucher disease type 1.

Authors:  Magdalena Cerón-Rodríguez; Edgar Barajas-Colón; Lyuva Ramírez-Devars; Claudia Gutiérrez-Camacho; Juan L Salgado-Loza
Journal:  Mol Genet Genomic Med       Date:  2017-10-25       Impact factor: 2.183
  2 in total
  1 in total

1.  Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials.

Authors:  Deborah Elstein; Nadia Belmatoug; Patrick Deegan; Özlem Göker-Alpan; Derralynn A Hughes; Ida Vanessa D Schwartz; Neal Weinreb; Nicola Bonner; Charlotte Panter; Donna Fountain; Andrew Lenny; Louise Longworth; Rachael Miller; Koonal Shah; Jörn Schenk; Rohini Sen; Ari Zimran
Journal:  Orphanet J Rare Dis       Date:  2022-01-06       Impact factor: 4.123
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.